↓ Skip to main content

Development of cabozantinib for the treatment of prostate cancer

Overview of attention for article published in Core Evidence, April 2014
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
54 Mendeley